Gene: CLDN23
Official Full Name: claudin 23provided by HGNC
Gene Summary: This gene encodes a member of the claudin family. Claudins are integral membrane proteins and components of tight junction strands. Tight junction strands serve as a physical barrier to prevent solutes and water from passing freely through the paracellular space between epithelial or endothelial cell sheets, and also play critical roles in maintaining cell polarity and signal transductions. This gene is expressed in germinal center B-cells, placenta and stomach as well as in colon tumor. This gene is down-regulated in intestinal type gastric cancer. [provided by RefSeq, Aug 2010]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO26360 | CLDN23 Knockout cell line (HeLa) | Human | CLDN23 | 1:3~1:6 | Negative | Online Inquiry |
KO26361 | CLDN23 Knockout cell line (HCT 116) | Human | CLDN23 | 1:2~1:4 | Negative | Online Inquiry |
KO26362 | CLDN23 Knockout cell line (A549) | Human | CLDN23 | 1:3~1:4 | Negative | Online Inquiry |
CLDN23 Gene Knockout Cell Lines are sophisticated biological tools specifically engineered to study the function of the CLDN23 gene, which encodes for the tight junction protein Claudin-23. These knockout cell lines offer a unique platform for researchers to dissect the involvement of CLDN23 in various physiological and pathological processes, including epithelial barrier integrity and cancer progression. The knockout mechanism is typically facilitated through CRISPR-Cas9 technology, which ensures precise and efficient disruption of the gene, resulting in functionally relevant models for experimental investigation.
These cell lines serve critical functions in unveiling the role of tight junctions in maintaining cellular homeostasis, enabling researchers to investigate how the absence of CLDN23 affects cellular signaling, permeability, and adhesion. They have significant implications in understanding claudin-mediated pathways in diseases such as colorectal cancer and other disorders characterized by barrier dysfunction. Moreover, the application potential extends to drug discovery and development since alterations in tight junction dynamics can impact therapeutic efficacy and safety.
What sets CLDN23 Gene Knockout Cell Lines apart from conventional models is their reliability and specificity. Unlike non-targeted methods, these cell lines guarantee the complete ablation of CLDN23, reducing off-target effects that could confound experimental results. Additionally, their ease of culture and adaptability to high-throughput screening methods enhance their practicality for rigorous and widespread use in laboratories.
Researchers and clinicians seeking to deepen their understanding of cell junction biology will find immense value in these knockout lines. Their design not only streamlines experimental workflows but also supports innovative research avenues capable of leading to breakthroughs in treatment strategies. With a proven track record in genetic research, our company stands at the forefront of providing high-quality biological products, ensuring that our customers have access to the best tools for their scientific explorations.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.